Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when perfor
CPT4 code
Name of the Procedure:
Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus detection (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription.
Summary
This procedure uses advanced technology to identify the genetic material (DNA or RNA) of various respiratory viruses in a patient. By doing so, it can quickly and accurately determine the presence of viruses such as influenza, coronavirus, and others in respiratory samples.
Purpose
Medical Condition: This test is used to diagnose respiratory infections. Goals: To accurately identify the viral cause of respiratory symptoms, enabling targeted treatment and management of the infection.
Indications
Symptoms: Persistent cough, fever, shortness of breath, nasal congestion, and other respiratory symptoms. Conditions: Suspected viral respiratory infections, especially when rapid identification is critical for treatment.
Preparation
- Instructions: No special preparation, fasting, or medication adjustments are typically needed.
- Assessment: A healthcare provider may perform a basic health check and review medical history.
Procedure Description
- Step-by-Step:
- A sample, usually a swab from the nose or throat, is collected.
- The genetic material (DNA/RNA) from the virus is extracted from the sample.
- Utilizing multiplex reverse transcription, multiple viruses can be detected simultaneously.
- Tools: Swabs, PCR (Polymerase Chain Reaction) machines, and specialized reagents.
- Anesthesia: Not required.
Duration
The procedure typically takes a few minutes for sample collection, while lab analysis may take several hours to a day.
Setting
The sample is collected in settings like hospitals, outpatient clinics, or doctors' offices and analyzed in specialized laboratories.
Personnel
- Healthcare Professionals: Nurses or technicians collect the samples. Laboratory specialists conduct and analyze the tests.
Risks and Complications
- Common Risks: Minor discomfort or irritation at the swab site.
- Rare Complications: In very rare cases, more significant discomfort or minor bleeding might occur.
Benefits
- Expected Benefits: Rapid and accurate identification of respiratory viruses, enabling timely and appropriate treatment.
- Realization Time: Results are typically available within 24-48 hours.
Recovery
- Post-procedure Care: No specific care required post-sample collection.
- Recovery Time: Immediate, as the sampling procedure is minimally invasive.
- Follow-up: Follow-up with healthcare provider for results and treatment plan.
Alternatives
- Other Options: Traditional culture methods, rapid antigen tests, or other molecular diagnostic tests.
- Comparison: These alternatives may take longer to deliver results or may not be as comprehensive in detecting multiple viruses at once.
Patient Experience
- During the Procedure: Patients might feel slight discomfort or tickling during the swab collection.
- After the Procedure: Generally, no pain or side effects; normal activities can be resumed immediately.
- Pain Management: Not required, as the procedure is quick and minimally invasive.